The CloudTMS system manufactured by Neurosoft Ltd is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.
Using the CloudTMS system for any indication(s) not currently cleared by the FDA is considered for investigational use only. By clicking agree or by using any techniques outlined in the video and text within, you indicate your agreement with these terms and conditions.I agree
Enabling instant results at the point of care
The revolutionary CloudEMG platform brings EMG & Nerve Conduction testing into the 21st century. Its parent company, TeleEMG.com, has been educating physicians in the field since 1996. CloudEMG helps practitioners worldwide address the millions of patients suffering from conditions such as Carpal Tunnel, Diabetic Peripheral Neuropathy, Lumbar/Neck radiculopathies, Ulnar Neuropathy, Chronic fatique syndrome, and Fibromyalgia, among others.
The data generated with the aid of TeleEMG’s devices, software, and services is intended to be an aid to properly trained healthcare professionals. Interpretation of the data, the diagnosis of medical conditions, and the subsequent development of treatment plans must be performed by and are the sole responsibility of appropriately trained healthcare professionals. Such interpretations and decisions must be made in the context of other patient specific medical information.
Subscribe for free and stay up to date with our training videos, protocols and TMS news.